hiPSC-RPE 2 (AMD 2) NAM
Homo sapiens
source_name
hiPSC-RPE 2 treated with Nicotinamide for 3 weeks
gender
female
age
73
disease status
Age related Macular degeneration (AMD)
treatment
Nicotinamide
tissue of origin
RPE